17 results
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
2021 ACR/VF Guidelines ... for Management ... of Giant Cell Arteritis ... ) #GiantCell #Arteritis ... #rheumatology #
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Rheumatoid Arthritis ... - ACR 2021 Guidelines ... #ACR2021 #Guidelines ... #management #treatment ... #rheumatology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... • Giant Cell Arteritis ... • Takayasu's arteritis ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
CPPD vs Gout

== CPPD == 

Think About CPPD When:
 • Self-limited synovitis after surgery/trauma (> 65
Arthritis: Monarticular ... inflammatory arthritis ... Inflammatory Arthritis ... • Metabolic syndrome ... Gout #Comparison #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Giant Cell Arteritis ... ) - Vasculitis Management ... - ACR/VF 2021 Guidelines ... GCA #Vasculitis #Management ... #algorithm #rheumatology
Pseudogout Summary - Calcium Pyrophosphate Deposition Disease (CPPD)

Pathophysiology:
Pyrophosphate produced by chondrocytes likely precipitates with calcium to
inflammatory arthritis ... Crowned Dens Syndrome ... crystal arthritis ... Deposition #Disease #Rheumatology ... #diagnosis #management
2021 ACR/VF Guidelines for Management of Takayasu Arteritis (TAK)

#Takayasu #Arteritis #TAK #ACR2021 #Management #rheumatology #algorithm #vasculitis
2021 ACR/VF Guidelines ... for Management ... of Takayasu Arteritis ... TAK) #Takayasu #Arteritis ... #rheumatology #
Behçet's Syndrome
Systemic disease associated with inflammation of multiple organs, small-vessel vasculitis and large-vessel vasculopathy
Epidemiology:
 • Young
Behçet's Syndrome ... SLE, Reactive arthritis ... SLE, Reactive Arthritis ... #diagnosis #management ... signs #symptoms #rheumatology
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome ... Antiphospholipid #Syndrome ... #APS #management ... #EULAR2019 #guidelines ... #rheumatology #
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
Macrophage Activation Syndrome ... juvenile idiopathic arthritis ... juvenile idiopathic arthritis ... #Diagnosis #Management ... #Hematology #Rheumatology